Startup profile · funding coverage
BCI-Sonics funding, valuation and investors
Shanghai neurotechnology startup developing non-invasive ultrasound brain-computer interfaces; raised RMB 200 million in a Pre-A round.
Keep track of BCI-Sonics
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Pre-A
RMB 200M · September 22, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
Stage not recorded · Shanghai, China
Investors in latest funding
Lead: HongShan , Yunqi Partners
Other: Proxima Capital , Oriza Holdings , Moral Stone Investment , Matrix Partners China , Delian Capital
Overview
BCI-Sonics (华超神控) develops non-invasive AI brain-computer interface systems using low-intensity focused ultrasound, multimodal brain reading and AI neural decoding. On September 22, 2026 it announced an RMB 200 million Pre-A round co-led by HongShan and Yunqi Partners. The company said cumulative financing since its 2025 founding was nearly RMB 300 million.
Why BCI-Sonics is interesting
The round is a large early-stage neurotech financing co-led by HongShan and Yunqi, with a technically differentiated non-invasive focused-ultrasound approach.
Key facts
- Sep 22, 2026: RMB 200M Pre-A
- HongShan and Yunqi Partners co-led
- Company said cumulative funding is nearly RMB 300M
Funding history (newest first)
Pre-A
2026-09-22 RMB 200M- HongShan (lead)
- Yunqi Partners (lead)
- Proxima Capital (participant)
- Oriza Holdings (participant)
- Moral Stone Investment (participant)
- Matrix Partners China (participant)
- Delian Capital (participant)
Source: https://m.chinaventure.com.cn/news/111-20260922-393402.html
Market / IPO context
Editorial / static context — not a live quote.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.